Insulin-like growth factor 1 receptor polymorphism rs2229765 and circulating interleukin-6 level affect male longevity in a population-based prospective study (Treviso Longeva− TRELONG)

Insulin-like growth factor 1 (IGF-1) signaling modulation has been associated with increased lifespan in model organisms, while high levels of circulating interleukin-6 (IL-6) are a marker of disability and mortality. In the prospective, population-based “Treviso Longeva”− TRELONG Study from Italy (n = 668, age range 70–105.5 years at baseline, followed for seven years) we investigated the effects of survival on the IGF-1 receptor (IGF-1R) gene polymorphism rs2229765, the IL-6 gene promoter polymorphism rs1800795, and plasma concentrations of IGF-1 and IL-6, alone or in combination. We found a sex-dependent effect for the IGF-1R rs2229765 polymorphism, as male carriers of the homozygous A/A genotype survived longer, while the IL-6 rs1800795 genotype did not influence overall or sex-specific longevity. Higher IL-6 levels were more detrimental for survival among males than females, while IGF-1 had no dose–response effect. These findings sustain the hypothesis that sex-specific longevity relies on detectable differences in genetic and biochemical parameters between males and females.

[1]  A. Bergman,et al.  Genetic studies reveal the role of the endocrine and metabolic systems in aging. , 2010, The Journal of clinical endocrinology and metabolism.

[2]  L. Poon,et al.  HRAS1 and LASS1 with APOE are associated with human longevity and healthy aging , 2010, Aging cell.

[3]  L. Kunkel,et al.  High-Density Genomewide Linkage Analysis of Exceptional Human Longevity Identifies Multiple Novel Loci , 2010, PloS one.

[4]  C. López-Otín,et al.  Insulin-like growth factor 1 treatment extends longevity in a mouse model of human premature aging by restoring somatotroph axis function , 2010, Proceedings of the National Academy of Sciences.

[5]  H. Daniel,et al.  Altered signalling from germline to intestine pushes daf‐2;pept‐1 Caenorhabditis elegans into extreme longevity , 2010, Aging cell.

[6]  A. Salminen,et al.  Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF-kappaB signaling. , 2010, Cellular signalling.

[7]  E. Barrett-Connor,et al.  Insulin-like growth factor-I and cancer mortality in older men. , 2010, The Journal of clinical endocrinology and metabolism.

[8]  M. Surks,et al.  Genetic predisposition to elevated serum thyrotropin is associated with exceptional longevity. , 2009, The Journal of clinical endocrinology and metabolism.

[9]  L. Polito,et al.  A polymorphic variant of the insulin-like growth factor 1 (IGF-1) receptor correlates with male longevity in the Italian population: a genetic study and evaluation of circulating IGF-1 from the "Treviso Longeva (TRELONG)" study , 2009, BMC geriatrics.

[10]  L. Polito,et al.  Interleukin-6 plasma level increases with age in an Italian elderly population (“The Treviso Longeva”–Trelong–study) with a sex-specific contribution of rs1800795 polymorphism , 2009, AGE.

[11]  C. Franceschi,et al.  Immunosenescence and Immunogenetics of Human Longevity , 2008, Neuroimmunomodulation.

[12]  Steven J. Lingard,et al.  Evidence for lifespan extension and delayed age–related biomarkers in insulin receptor substrate 1 null mice , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  Amy R. Cameron,et al.  Black tea polyphenols mimic insulin/insulin‐like growth factor‐1 signalling to the longevity factor FOXO1a , 2008, Aging cell.

[14]  S. Bandinelli,et al.  Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study. , 2007, Archives of internal medicine.

[15]  Cynthia Kenyon,et al.  DAF-16/FOXO targets genes that regulate tumor growth in Caenorhabditis elegans , 2007, Nature Genetics.

[16]  Stuart K. Kim.  Common aging pathways in worms, flies, mice and humans , 2007, Journal of Experimental Biology.

[17]  R. Westendorp,et al.  Regulation of Human Life Histories , 2007, Annals of the New York Academy of Sciences.

[18]  J. Hoeijmakers,et al.  A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis , 2006, Nature.

[19]  I. Ilias,et al.  Interleukin‐6 , 2006, Annals of the New York Academy of Sciences.

[20]  Burton H Singer,et al.  Combinations of biomarkers predictive of later life mortality , 2006, Proceedings of the National Academy of Sciences.

[21]  J. Sorkin,et al.  Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men. , 2006, American journal of physiology. Endocrinology and metabolism.

[22]  G. Lithgow,et al.  Using Caenorhabditis elegans as a Model for Aging and Age‐Related Diseases , 2006, Annals of the New York Academy of Sciences.

[23]  T. Lehtimäki,et al.  Interleukin-6 −174G/C polymorphism and longevity: a follow-up study , 2005, Mechanisms of Ageing and Development.

[24]  L. Christiansen,et al.  Modest implication of interleukin-6 promoter polymorphisms in longevity , 2004, Mechanisms of Ageing and Development.

[25]  E. Arvat,et al.  Ageing, growth hormone and physical performance , 2003, Journal of endocrinological investigation.

[26]  Cori Bargmann,et al.  Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans , 2003, Nature.

[27]  C. Franceschi,et al.  Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control. , 2003, The Journal of clinical endocrinology and metabolism.

[28]  L. Ferrucci,et al.  Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. , 2003, The Journal of clinical endocrinology and metabolism.

[29]  C. Franceschi,et al.  Centenarians as a model for healthy aging. , 2003, Biochemical Society transactions.

[30]  T. Perls.  Genetic and Environmental Influences on Exceptional Longevity and the AGE Nomogram , 2002, Annals of the New York Academy of Sciences.

[31]  C. Franceschi,et al.  A gender–dependent genetic predisposition to produce high levels of IL‐6 is detrimental for longevity , 2001, European journal of immunology.

[32]  J S Yudkin,et al.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.

[33]  M McGue,et al.  Longevity is moderately heritable in a sample of Danish twins born 1870-1880. , 1993, Journal of gerontology.

[34]  P. Hildebrandt,et al.  IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. , 2009, European journal of endocrinology.

[35]  T. Lehtimäki,et al.  Interleukin-1 Receptor Antagonist, Interleukin-6, and C-Reactive Protein as Predictors of Mortality in Nonagenarians: The Vitality 90 þ Study , 2007 .

[36]  L. Polito,et al.  Associations of the plasma interleukin 6 (IL-6) levels with disability and mortality in the elderly in the Treviso Longeva (Trelong) study. , 2007, Archives of gerontology and geriatrics.

[37]  S. Mazzuco,et al.  The Treviso Longeva (Trelong) study: a biomedical, demographic, economic and social investigation on people 70 years and over in a typical town of North-East of Italy. , 2007, Archives of gerontology and geriatrics.

[38]  F. Panza,et al.  Interleukin 6-174 G/C promoter gene polymorphism in centenarians: no evidence of association with human longevity or interaction with apolipoprotein E alleles. , 2004, Experimental gerontology.

[39]  M. Thorén,et al.  Determinants of circulating insulin-like growth factor-I. , 1999, Journal of endocrinological investigation.

[40]  A. Boccuzzi,et al.  Twenty-four hour profile of blood pressure in patients with acromegaly. Correlation with demographic, clinical and hormonal features , 1999, Journal of endocrinological investigation.